Crestchem Ltd

Crestchem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Crestchem Ltd

₹ 138 1.36%
02 Jun - close price
crestchemlimited.in BSE: 526269
About

Incorporated in 1991, Crestchem Ltd is in
the field of processing, manufacturing, and trading and marketing, of specialty chemical
ingredients,[1]

Key Points

Business Overview:[1][2][3]
CL specializes in manufacturing, processing, marketing, and exporting nutraceutical ingredients used in health food, personal care, and specialty chemicals. Its key products, Caprylic/Capric Triglycerides in oil and powder form, along with downstream derivatives, also have industrial applications.

Website BSE
  • Market Cap ₹ 41.4 Cr.
  • Current Price ₹ 138
  • High / Low ₹ 193 / 73.0
  • Stock P/E 15.3
  • Book Value ₹ 33.0
  • Dividend Yield 0.73 %
  • ROCE %
  • ROE 27.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 4.18 times its book value
  • Promoter holding is low: 30.0%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
10.23
8.83
Operating Profit 1.40
OPM % 13.69%
0.20
Interest 0.01
Depreciation 0.02
Profit before tax 1.57
Tax % 30.57%
1.10
EPS in Rs 3.67
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
29.61
26.43
Operating Profit 3.18
OPM % 10.74%
0.66
Interest 0.01
Depreciation 0.07
Profit before tax 3.76
Tax % 27.93%
2.71
EPS in Rs 9.03
Dividend Payout % 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: 31%
5 Years: 31%
3 Years: 14%
1 Year: -22%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
Equity Capital 3.00
Reserves 6.89
0.00
6.35
Total Liabilities 16.24
0.19
CWIP 0.00
Investments 0.00
16.05
Total Assets 16.24

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2026
Debtor Days 44.50
Inventory Days 0.00
Days Payable
Cash Conversion Cycle 44.50
Working Capital Days -12.70
ROCE %

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Customer Concentration (Top Customer Revenue Share)
% ・Standalone data
Concentration (Top 3 Customers Revenue Share)
% ・Standalone data
Research and Technology Expenses
INR Thousands ・Standalone data
Number of Reportable Business Segments
Count ・Standalone data
Core Product Forms (Caprylic/Capric Triglycerides)
Count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

8 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
31.65% 31.92% 32.09% 32.11% 32.05% 32.04% 32.12% 32.21% 29.43% 29.69% 29.94% 30.04%
0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13% 0.13%
68.22% 67.95% 67.78% 67.75% 67.82% 67.83% 67.77% 67.66% 70.45% 70.19% 69.93% 69.83%
No. of Shareholders 11,45011,46111,51011,45611,93112,42312,96612,88612,84312,85112,68212,619

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports